BEST UNLIMITED TURBO LONG CERTIFICATE - ELI LILLY & CO | Market Closed - Borsa Italiana 01:34:59 15/06/2024 am IST | ||
| 33.22 EUR | -1.19% |
|
| Current month | +21.07% | ||
| 1 month | +48.30% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 14/24/14 | 33.62 | 0.00% |
| 13/24/13 | 33.62 | +4.51% |
| 12/24/12 | 32.17 | +0.31% |
| 11/24/11 | 32.07 | +0.22% |
| 10/24/10 | 32 | +4.85% |
Real-time Borsa Italiana
Last update June 15, 2024 at 01:34 am IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Société Générale
|
| S33389 | |
| ISIN | DE000SU58T38 |
| Date issued | 28/12/2023 |
| Strike | 525.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 34.8 € |
|---|---|
| Lowest since issue | 7.14 € |
| Spread | 0.15 € |
| Spread % | 0.45% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
878.4
USD
Average target price
855.4
USD
Spread / Average Target
-2.63%
- Stock Market
- Certificates
- S33389 Certificat
